TY - JOUR
T1 - MicroRNA Profiling in the Perilymph of Cochlear Implant Patients
T2 - Identifying Markers that Correlate to Audiological Outcomes
AU - Wichova, Helena
AU - Shew, Matthew
AU - Nelson-Brantley, Jennifer
AU - Warnecke, Athanasia
AU - Prentiss, Sandra
AU - Staecker, Hinrich
N1 - Funding Information:
The authors would like to thank the University of Kansas Medical Center Genomics Core funded by Kansas Intellec-
Publisher Copyright:
© 2021 American Academy of Audiology. All rights reserved.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Hypothesis MicroRNA (miRNA) expression profiles from human perilymph correlate to post cochlear implantation (CI) hearing outcomes. Background The high inter-individual variability in speech perception among cochlear implant recipients is still poorly understood. MiRNA expression in perilymph can be used to characterize the molecular processes underlying inner ear disease and to predict performance with a cochlear implant. Methods Perilymph collected during CI from 17 patients was analyzed using microarrays. MiRNAs were identified and multivariable analysis using consonant-nucleus-consonant testing at 6 and 18 months post implant activation was performed. Variables analyzed included age, gender, preoperative pure tone average (PTA), and preoperative speech discrimination (word recognition [WR]). Gene ontology analysis was performed to identify potential functional implications of changes in the identified miRNAs. Results Distinct miRNA profiles correlated to preoperative PTA and WR. Patients classified as poor performers showed downregulation of six miRNAs that potentially regulate pathways related to neuronal function and cell survival. Conclusion Individual miRNA profiles can be identified in microvolumes of perilymph. Distinct non-coding RNA expression profiles correlate to preoperative hearing and postoperative cochlear implant outcomes.
AB - Hypothesis MicroRNA (miRNA) expression profiles from human perilymph correlate to post cochlear implantation (CI) hearing outcomes. Background The high inter-individual variability in speech perception among cochlear implant recipients is still poorly understood. MiRNA expression in perilymph can be used to characterize the molecular processes underlying inner ear disease and to predict performance with a cochlear implant. Methods Perilymph collected during CI from 17 patients was analyzed using microarrays. MiRNAs were identified and multivariable analysis using consonant-nucleus-consonant testing at 6 and 18 months post implant activation was performed. Variables analyzed included age, gender, preoperative pure tone average (PTA), and preoperative speech discrimination (word recognition [WR]). Gene ontology analysis was performed to identify potential functional implications of changes in the identified miRNAs. Results Distinct miRNA profiles correlated to preoperative PTA and WR. Patients classified as poor performers showed downregulation of six miRNAs that potentially regulate pathways related to neuronal function and cell survival. Conclusion Individual miRNA profiles can be identified in microvolumes of perilymph. Distinct non-coding RNA expression profiles correlate to preoperative hearing and postoperative cochlear implant outcomes.
KW - biomarker
KW - cochlear implant outcomes
KW - miRNA
KW - perilymph sampling
UR - http://www.scopus.com/inward/record.url?scp=85130678319&partnerID=8YFLogxK
U2 - 10.1055/s-0041-1742234
DO - 10.1055/s-0041-1742234
M3 - Article
C2 - 35609590
AN - SCOPUS:85130678319
SN - 1050-0545
VL - 32
SP - 627
EP - 635
JO - Journal of the American Academy of Audiology
JF - Journal of the American Academy of Audiology
IS - 10
ER -